{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T01:19:51Z","timestamp":1768007991589,"version":"3.49.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T00:00:00Z","timestamp":1584576000000},"content-version":"vor","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.heliyon.2020.e03639","type":"journal-article","created":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T06:33:20Z","timestamp":1585636400000},"page":"e03639","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Quantum modelling and molecular docking evaluation of some selected quinoline derivatives as anti-tubercular agents"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7750-8174","authenticated-orcid":false,"given":"Shola Elijah","family":"Adeniji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gideon","family":"Adamu Shallangwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Ebuka Arthur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustapha","family":"Abdullahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.Y.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdurrashid","family":"Haruna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2020.e03639_bib1","author":"W.H.O."},{"key":"10.1016\/j.heliyon.2020.e03639_bib2","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1021\/cr0000067","article-title":"Chem-bioinformatics and QSAR: a review of QSAR lacking positive hydrophobic terms","volume":"101","author":"Hansch","year":"2001","journal-title":"Chem. Rev."},{"key":"10.1016\/j.heliyon.2020.e03639_bib3","first-page":"117","article-title":"Synthesis and anti-tuberculosis activity of 2, 4-disubstituted quinolines","volume":"47","author":"Nayyar","year":"2008","journal-title":"Indian J. Chem."},{"key":"10.1016\/j.heliyon.2020.e03639_bib4","article-title":"QSAR modeling and molecular docking analysis of some active compounds against M.\u00a0tuberculosis receptor (Mtb CYP121)","volume":"2018","author":"Adeniji","year":"2018","journal-title":"J.\u00a0Pathog."},{"key":"10.1016\/j.heliyon.2020.e03639_bib5","first-page":"1","article-title":"Analysis of selected chalcone derivatives as M.\u00a0tuberculosis inhibitors","volume":"3","author":"Ogadimma","year":"2016","journal-title":"Open Access Library J."},{"key":"10.1016\/j.heliyon.2020.e03639_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9734\/JSRR\/2016\/23176","article-title":"A\u00a0quantitative structure-activity relationship (QSAR) study of the anti-tuberculosis activity of some quinolines","volume":"10","author":"Eric","year":"2016","journal-title":"J.\u00a0Sci. Res. Rep."},{"key":"10.1016\/j.heliyon.2020.e03639_bib7","first-page":"479","article-title":"A\u00a0novel QSAR model for the evaluation and prediction of (E)-N\u2019-Benzylideneisonicotinohydrazide derivatives as the potent anti-M.\u00a0tuberculosis Antibodies using genetic function approach","volume":"6","author":"Adeniji","year":"2018","journal-title":"Phys. Chem. Res."},{"key":"10.1016\/j.heliyon.2020.e03639_bib8","first-page":"64","article-title":"Quantitative structure-activity relationship study of substituted-[1, 2, 4] oxadiazoles as S1P1 Agonists","volume":"3","author":"Singh","year":"2013","journal-title":"J.\u00a0Curr. Chem. Pharm. Sci."},{"key":"10.1016\/j.heliyon.2020.e03639_bib9","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5173786","article-title":"A\u00a0derived QSAR model for predicting some compounds as potent Antagonist against M.\u00a0tuberculosis: a theoretical approach","author":"Adeniji","year":"2019","journal-title":"Hindawi Adv. Prev. Med."},{"key":"10.1016\/j.heliyon.2020.e03639_bib10","first-page":"69","article-title":"The importance of being earnest: validation is the absolute essential for successful application and interpretation of QSPR models","volume":"22","author":"Tropsha","year":"2003","journal-title":"Mol. Inform."},{"key":"10.1016\/j.heliyon.2020.e03639_bib11","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/jcc.23231","article-title":"Some case studies on application of \u201crm2\u201d metrics for judging quality of quantitative structure\u2013activity relationship predictions: emphasis on scaling of response data","volume":"34","author":"Roy","year":"2013","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.heliyon.2020.e03639_bib12","first-page":"511","article-title":"Validation of QSAR models-strategies and importance","volume":"3","author":"Veerasamy","year":"2011","journal-title":"Int. J. Drug Des. Discov."},{"key":"10.1016\/j.heliyon.2020.e03639_bib13","first-page":"8 1","article-title":"Multi-linear regression model, molecular binding interactions and ligand-based design of some prominent compounds against M.\u00a0tuberculosis","volume":"9","author":"Adeniji","year":"2020","journal-title":"Netw. Model. Anal. Health Informat. Bioinformat."},{"key":"10.1016\/j.heliyon.2020.e03639_bib14","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.fjps.2018.10.003","article-title":"Theoretical modeling and molecular docking simulation for investigating and evaluating some active compounds as potent anti-tubercular agents against MTB CYP121 receptor","volume":"4","author":"Adeniji","year":"2018","journal-title":"Future J. Pharmaceut. sci."},{"key":"10.1016\/j.heliyon.2020.e03639_bib15","author":"Piton"},{"key":"10.1016\/j.heliyon.2020.e03639_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e03158","article-title":"In-silico activity prediction and docking studies of some 2, 9-disubstituted 8-phenylthio\/phenylsulfinyl-9h-purine derivatives as Anti-proliferative agents","volume":"6","author":"T Ibrahim","year":"2020","journal-title":"Heliyon"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844020304849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844020304849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T10:37:49Z","timestamp":1742294269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844020304849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S2405844020304849"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2020.e03639","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantum modelling and molecular docking evaluation of some selected quinoline derivatives as anti-tubercular agents","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2020.e03639","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e03639"}}